Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

6.940 +0.250 (+3.74%)
Streaming Delayed Price Updated: 3:59 PM EST, Nov 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
65 66 Next >
News headline image
Top 6 Nasdaq Short Squeeze Play Stocks ↗
The following are some heavily shorted tech stocks that may be worth considering. 
Via Talk Markets
News headline image
Pfizer Reportedly Hikes Paxlovid Price To $1,390 — More Than Double What The Government Paid ↗
The transition to the commercial market is planned for 2024 and could bolster sales. 
Via Investor's Business Daily
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Do These 5 Words From Pfizer Mean Trouble for Novavax? ↗
Coronavirus vaccine sales could represent recurrent annual revenue for Novavax and rivals. 
Via The Motley Fool
News headline image
Bitcoin's ETF Approval Rumor, Pfizer Slashes Annual Outlook, Activist Shareholder Shakes Up News Corp's Status Quo: Today's Top Stories ↗
Benzinga Bitcoin Spiked On False ETF Approval Rumor 
Via Benzinga
Topics ETFs
News headline image
The Fall Vaccination Season Is Here. Is Novavax a Buy? ↗
Novavax shares have declined 28% this year. 
Via The Motley Fool
News headline image
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday. 
Via Benzinga
News headline image
Moderna, BioNTech Lead Covid Sell-Off After Pfizer Slashes Its Outlook By $9 Billion ↗
Pfizer cut about $9 billion from its sales expectations for Covid products this year. 
Via Investor's Business Daily
News headline image
Novavax Faces Setback, European Authority Delays Decision On Variant-Tailored COVID-19 Vaccine ↗
Novavax Inc (NASDAQ: NVAX) faces a setback as the European Medicines Agency (EMA) delays a decision on its variant-tailored COVID-19 vaccine.  
Via Benzinga
News headline image
The 10 Most Shorted Stocks Include 3 Tesla Rivals, But Not TSLA ↗
Some big 2023 winners are shorted heavily, including two AI plays. 
Via Investor's Business Daily
Topics Artificial Intelligence
News headline image
US Stocks On Track For A Strong Start To Week, Buoyed By Earnings Optimism: Analyst Flags 13-14% Upside As Bull Market Enters Its Second Year ↗
US stocks appear on track to start higher on Monday as traders look ahead to the earnings season to serve as upside catalyst. 
Via Benzinga
News headline image
BioNTech, Moderna And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
News headline image
Is Novavax Stock a Buy Now? ↗
Is this company just a pandemic stock? 
Via The Motley Fool
News headline image
Novavax (NVAX) Stock Slides Despite Vaccine Availability ↗
Although Novavax’s non-mRNA vaccine being available broadly represents good news, NVAX stock suffered due to unfavorable timing. 
Via InvestorPlace
News headline image
Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in... 
Via Benzinga
News headline image
AZZ, VOXX International And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded higher Wednesday, with the Dow Jones gaining around 100 points. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
News headline image
The COVID Vaccine Market Is Changing Dramatically. Do Vaccine Stocks Still Make Good Investments? ↗
Vaccine revenue may have slipped but could still represent billions of dollars for these companies. 
Via The Motley Fool
News headline image
Timing Favors Novavax's Delayed Approval, Arrival Ahead of Peak COVID Vaccine Demand ↗
Last week, Novavax Inc (NASDAQ: NVAX) received FDA authorization for its updated COVID-19 vaccine, targeting the omicron subvariant XBB.1.5 in  
Via Benzinga
News headline image
3 Pharma Stocks to Dump Before the Damage Is Done ↗
There's never a shortage of pharma stocks to sell due to the nature of the sector, especially when compounded by current fears. 
Via InvestorPlace
News headline image
This Could be Novavax's Big Opportunity ↗
Novavax has lagged behind bigger rivals in the vaccine market. 
Via The Motley Fool
News headline image
Did Moderna Just Jump Ahead of Rivals in a Potential Billion-Dollar Market? ↗
Moderna, Pfizer, and Novavax all are working on combined vaccine candidates. 
Via The Motley Fool
News headline image
Why Novavax Stock Fell Today ↗
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower Wednesday amid a pullback in the stock, which gained Tuesday after the FDA granted Emergency Use Authorization for the company's updated... 
Via Benzinga
News headline image
Novavax's COVID-19 Shot Just In Time, Optimism Surrounds As Demand Picks Up Momentum ↗
Tuesday, the FDA granted an emergency use nod to Novavax Inc's (NASDAQ: NVAX) COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) (NVX-CoV2601) for active immunization to prevent COVID-19 in  
Via Benzinga
News headline image
Why Is Tilray (TLRY) Stock Down 4% Today? ↗
Tilray has released its earnings report for its fiscal first quarter of 2024 and mixed results have TLRY stock on a wild ride today! 
Via InvestorPlace
News headline image
These Apple Insiders Are Selling Shares of AAPL Stock ↗
Apple stock is on the move Wednesday after several insiders at the company, including CEO Tim Cook, sold shares of AAPL. 
Via InvestorPlace
News headline image
Short Sellers Are Betting Against Novavax (NVAX) Stock ↗
Shorts are betting no one will want Novavax's Covid-19 vaccine, but the pandemic is not yet over, and NVAX stock is cheap. 
Via InvestorPlace
News headline image
What's Going On With Moderna Stock Wednesday? ↗
Moderna, Inc (NASDAQ: MRNA) shares are trading higher Wednesday. 
Via Benzinga
News headline image
Trump's SPAC Partner Digital World, Novavax, Palantir, And Tesla: Why These Stocks Are Trending Today? ↗
U.S. stocks experienced a downturn, with significant losses noted toward the end of trading. The S&P 500 fell approximately 1.4%. 
Via Benzinga
Topics Government Stocks
News headline image
Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna ↗
The company can now join Pfizer and Moderna in launching an updated booster in the U.S. 
Via Investor's Business Daily
News headline image
Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On? ↗
Novavax Inc (NASDAQ: NVAX) shares are surging Tuesday afternoon after the U.S. 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
65 66 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.